Bacterial Proteins and Peptides as Potential Anticancer Agents : A Novel Search for Protein-based Therapeutics
Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net..
Tumor diseases remain among the world's primary causes of death despite substantial advances in cancer diagnosis and treatment. The adverse chemotherapy problems and sensitivity towards drugs for some cancer types are among the most promising challenges in modern treatment. Finding new anti-cancer agents and drugs is, therefore, essential. A significant class of biologically active substances and prospective medications against cancer is comprised of bacterial proteins and peptides. Among these bacterial peptides, some of them, such as anti-cancer antibiotics and many toxins like diphtheria are widely being used in the treatment of cancer. In contrast, the remaining bacterial peptides are either in clinical trials or under research in vitro studies. This study includes the most recent information on the characteristics and mechanism of action of the bacterial peptides that have anti-cancer activities, some of which are now being employed in cancer therapy while some are still undergoing research.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - year:2024 |
---|---|
Enthalten in: |
Current medicinal chemistry - (2024) vom: 07. Feb. |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Pyla, Mahitha [VerfasserIn] |
---|
Links: |
---|
Themen: |
Anti-cancer antibiotics |
---|
Anmerkungen: |
Date Revised 09.02.2024 published: Print-Electronic Citation Status Publisher |
---|
doi: |
10.2174/0109298673253414231127162817 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM368234622 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM368234622 | ||
003 | DE-627 | ||
005 | 20240209232232.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240209s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.2174/0109298673253414231127162817 |2 doi | |
028 | 5 | 2 | |a pubmed24n1285.xml |
035 | |a (DE-627)NLM368234622 | ||
035 | |a (NLM)38333973 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Pyla, Mahitha |e verfasserin |4 aut | |
245 | 1 | 0 | |a Bacterial Proteins and Peptides as Potential Anticancer Agents |b A Novel Search for Protein-based Therapeutics |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 09.02.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status Publisher | ||
520 | |a Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net. | ||
520 | |a Tumor diseases remain among the world's primary causes of death despite substantial advances in cancer diagnosis and treatment. The adverse chemotherapy problems and sensitivity towards drugs for some cancer types are among the most promising challenges in modern treatment. Finding new anti-cancer agents and drugs is, therefore, essential. A significant class of biologically active substances and prospective medications against cancer is comprised of bacterial proteins and peptides. Among these bacterial peptides, some of them, such as anti-cancer antibiotics and many toxins like diphtheria are widely being used in the treatment of cancer. In contrast, the remaining bacterial peptides are either in clinical trials or under research in vitro studies. This study includes the most recent information on the characteristics and mechanism of action of the bacterial peptides that have anti-cancer activities, some of which are now being employed in cancer therapy while some are still undergoing research | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a anti-cancer antibiotics | |
650 | 4 | |a anti-cancer drugs | |
650 | 4 | |a anti-cancer enzymes | |
650 | 4 | |a bacterial peptides | |
650 | 4 | |a bacterial toxins | |
650 | 4 | |a bacteriocins | |
650 | 4 | |a cancer | |
650 | 4 | |a no ribosomal peptides | |
700 | 1 | |a Kankipati, Sanjana |e verfasserin |4 aut | |
700 | 1 | |a Sumithra, B |e verfasserin |4 aut | |
700 | 1 | |a Mishra, Piyush Kumar |e verfasserin |4 aut | |
700 | 1 | |a Mishra, Bishwambhar |e verfasserin |4 aut | |
700 | 1 | |a Mandal, Sanjeeb Kumar |e verfasserin |4 aut | |
700 | 1 | |a Panda, Jibanjyoti |e verfasserin |4 aut | |
700 | 1 | |a Chopra, Hitesh |e verfasserin |4 aut | |
700 | 1 | |a Satya Kumar, Avula |e verfasserin |4 aut | |
700 | 1 | |a Salah, Mohamed |e verfasserin |4 aut | |
700 | 1 | |a Mohanta, Yugal Kishore |e verfasserin |4 aut | |
700 | 1 | |a Kamal, Mohammad Amjad |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Current medicinal chemistry |d 1997 |g (2024) vom: 07. Feb. |w (DE-627)NLM093833857 |x 1875-533X |7 nnns |
773 | 1 | 8 | |g year:2024 |g day:07 |g month:02 |
856 | 4 | 0 | |u http://dx.doi.org/10.2174/0109298673253414231127162817 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |j 2024 |b 07 |c 02 |